wow-inequalities/02-data/intermediate/wos_sample/d180d655ac6e258476c909104dc41338-meyer-rosberg-k-and/info.yaml

114 lines
3.6 KiB
YAML
Raw Normal View History

2023-09-28 14:46:10 +00:00
abstract: 'The present study was undertaken to assess the health-related quality of
life (HRQoL) and burden of illness due to pain and its treatment for
patients with peripheral neuropathic pain (PNP). It is the first step in
finding reliable instruments/targets to evaluate treatment outcome in
this patient population. Study population consisted of 126 patients
suffering from neuropathic, pain due to a peripheral nerve or root
lesion, recruited from two multidisciplinary pain clinics. HRQoL was
examined using Short Form 36 (SF-36) Health Survey and Nottingham Health
Profile (NHP). Pain intensity in four categories (at rest and evoked by
movement, touch and cold) was rated on a visual analogue scale (VAS).
Degree of discomfort from pain and 25 symptoms related to pain and
side-effects was also assessed. Reduction in workload due to pain was
recorded, as was the pain relief from previous and current treatments
and the reasons for discontinuing previous treatments.
All dimensions in SF-36 and NHP were significantly impaired. SF-36 was a
valid instrument for describing the impact of pain on the HRQoL of
patients with PNP. NHP had a lower reliability but has other advantages
that might be of importance. Many patients experienced poor pain relief
from ongoing pain treatments. Most previous treatments were discontinued
owing to lack of efficacy and/or severe side-effects. Many patients
experienced a high intensity of at least one type of pain; median VAS
for the highest pain intensity score of each patient (any type of pain)
was 74/100. Besides pain, patients were most bothered by difficulty in
sleeping, lack of energy, drowsiness, difficulty in concentrating and
dry mouth. Employment status was reduced owing to pain in 52\% of the
patients.
The intense pain, other troublesome symptoms, limited efficacy and
tolerability of available treatments, together with the impaired health
and reduced work status, amount to a substantial burden for patients
with PNP. (C) 2001 European Federation of Chapters of the International
Association for the Study of Pain.'
affiliation: 'Astra Pain Control AB, SE-15185 Sodertalje, Sweden.
Univ Uppsala Hosp, Dept Anesthesiol \& Intens Care, Acad Hosp, SE-75105 Uppsala,
Sweden.
Danderyd Hosp, Dept Anesthesiol \& Intens Care, SE-18288 Stockholm, Sweden.'
author: Meyer-Rosberg, K and Kvarnstrom, A and Kinnman, E and Gordh, T and Nordfors,
LO and Kristofferson, A
author-email: karin.meyer-rosberg@quintiles.com
author_list:
- family: Meyer-Rosberg
given: K
- family: Kvarnstrom
given: A
- family: Kinnman
given: E
- family: Gordh
given: T
- family: Nordfors
given: LO
- family: Kristofferson
given: A
da: '2023-09-28'
doi: 10.1053/eujp.2001.0259
eissn: 1532-2149
files: []
issn: 1090-3801
journal: EUROPEAN JOURNAL OF PAIN
keywords: 'peripheral neuropathic pain; peripheral nerve injury; nerve root lesion;
SF-36; Nottingham Health Profile; health related quality of life; rating
scale'
keywords-plus: 'QUALITY-OF-LIFE; RANDOMIZED CONTROLLED TRIAL; HEALTH SURVEY SF-36;
GABAPENTIN; VALIDITY; DISEASE'
language: English
number: '4'
number-of-cited-references: '25'
orcid-numbers: Gordh, Torsten/0000-0003-1454-3148
pages: 379-389
papis_id: 5a20a2b52ded89796b26acf6eb1de806
ref: Meyerrosberg2001peripheralneuropathi
times-cited: '173'
title: Peripheral neuropathic pain - a multidimensional burden for patients
2023-10-01 08:15:07 +00:00
type: article
2023-09-28 14:46:10 +00:00
unique-id: WOS:000173508300006
usage-count-last-180-days: '1'
usage-count-since-2013: '17'
volume: '5'
web-of-science-categories: Anesthesiology; Clinical Neurology; Neurosciences
year: '2001'